Next Article in Journal
The Role of Interleukin-18, Oxidative Stress and Metabolic Syndrome in Alzheimer’s Disease
Next Article in Special Issue
Pathophysiology of Hemophilic Arthropathy
Previous Article in Journal
The Soft- and Hard-Heartedness of Cardiac Fibroblasts: Mechanotransduction Signaling Pathways in Fibrosis of the Heart
Previous Article in Special Issue
Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX
Article Menu

Export Article

Open AccessFeature PaperReview
J. Clin. Med. 2017, 6(5), 54; doi:10.3390/jcm6050054

Hemophilia Care in the Pediatric Age

1
Thrombosis and Hemostasis Unit, Regional Reference Center for Hemorrhagic Diseases, Giannina Gaslini Children’s Hospital, 16147 Genova, Italy
2
Hematology Unit, Giannina Gaslini Children’s Hospital, 16147 Genova, Italy
*
Author to whom correspondence should be addressed.
Academic Editors: Massimo Morfini and Giovanni Di Minno
Received: 31 January 2017 / Revised: 12 May 2017 / Accepted: 16 May 2017 / Published: 19 May 2017
(This article belongs to the Special Issue Outstanding Advances in Hemophilia Therapies)
View Full-Text   |   Download PDF [239 KB, uploaded 22 May 2017]

Abstract

Hemophilia is the most common of the severe bleeding disorders and if not properly managed since early infancy can lead to chronic disease and lifelong disabilities. However, it enjoys the most efficacious and safe treatment among the most prevalent monogenic disorders. Hemophilia should be considered in the neonatal period in the case of unusual bleeding or in the case of positive family history. Later, hemophilia should be suspected mainly in males because of abnormal bruising/bleeding or unusual bleeding following invasive procedures—for example, tonsillectomy or circumcision. Prophylactic treatment that is started early with clotting-factor concentrates has been shown to prevent hemophilic arthropathy and is, therefore, the gold standard of care for hemophilia A and B in most countries with adequate resources. Central venous access catheters and arterovenous fistulas play an important role in the management of hemophilia children requiring repeated and/or urgent administration of coagulation factor concentrates. During childhood and adolescence, personalized treatment strategies that suit the patient and his lifestyle are essential to ensure optimal outcomes. Physical activity is important and can contribute to better coordination, endurance, flexibility and strength. The present article focuses also on questions frequently posed to pediatric hematologists like vaccinations, day-care/school access and dental care. View Full-Text
Keywords: hemophilia; neonate; child; treatment; prophylaxis; vaccinations; sport; psychology; venous access hemophilia; neonate; child; treatment; prophylaxis; vaccinations; sport; psychology; venous access
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bertamino, M.; Riccardi, F.; Banov, L.; Svahn, J.; Molinari, A.C. Hemophilia Care in the Pediatric Age. J. Clin. Med. 2017, 6, 54.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top